May 29, 2017
Recommended Topic Related To:

Cystaran

"Most of us share a common color vision sensory experience. Some people, however, have a color vision deficiency, which means their perception of colors is different from what most of us see. The most severe forms of these deficiencies are refer"...

A A A

Cystaran




Cystaran Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

Last reviewed on RxList 6/14/2016

Cystaran (cysteamine) Ophthalmic Solution is a cystine-depleting agent used to treat corneal cystine crystal accumulation in patients with cystinosis. Common side effects of Cystaran Ophthalmic Solution include:

  • sensitivity to light
  • eye redness
  • eye pain or irritation
  • headache, and
  • visual field defects

The dose of Cystaran is to instill one drop in each eye, every waking hour. Cystaran may interact with other drugs. Tell your doctor all medications and supplements you use. During pregnancy, Cystaran should be used only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

Our Cystaran (cysteamine) Ophthalmic Solution Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Cystaran FDA Prescribing Information: Side Effects
(Adverse Reactions)

SIDE EFFECTS

Clinical Studies Experience

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

The safety data described below reflect exposure in controlled clinical trials of six months to 19 years duration in approximately 300 patients.

The most frequently reported ocular adverse reactions occurring in ≥ 10% of patients were sensitivity to light, redness, and eye pain/irritation, headache and visual field defects.

Read the entire FDA prescribing information for Cystaran (Cysteamine Ophthalmic Solution)

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


WebMD Daily

Get breaking medical news.